BioVie Inc. Goodwill and Intangible Asset Impairment
BioVie Inc. (BIVI) reported Goodwill and Intangible Asset Impairment of $0 for the 12-month period ending 2023-06-30, per its 10-K filed 2023-08-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2023-08-16
- BioVie Inc. goodwill and intangible asset impairment for fiscal 2023 was $0.00.
- BioVie Inc. goodwill and intangible asset impairment for fiscal 2022 was $0.00.
| Period end | Goodwill and Intangible Asset Impairment 12 month |
|---|---|
| 2023-06-30 | $0.00 10-K · filed 2023-08-16 |
| 2022-06-30 | $0.00 10-K · filed 2023-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |